How the world’s most comprehensive biomedical database will enable the discovery of new drug treatments

Professor Naveed Sattar, Professor of Metabolic Medicine, University of Glasgow

UK Biobank: large, deep, long and accessible 
Professor Naomi Allen
Chief Scientist, UK Biobank, United Kingdom

Identifying drug targets using UK Biobank exome sequencing data
Dr Abhishek Nag
Associate Principal Scientist, AstraZeneca

Global collaboration and the use of the UK Biobank resource for drug discovery
Dr Adrian Cortes
Scientific Director, GSK

Leveraging UK Biobank for precision medicine-focused innovation in biotech
Dr Mary Helen Black
VP, Head of Human Genomics, Foresite Labs

The value of large-scale proteomics for understanding mechanisms
Dr Chris Whelan
Director, Neuroscience Data Science at Johnson & Johnson

Cloud-based computing for global collaboration and drug discovery
Dr Asha Collins
General Manager, Biobanks Data Analysis Platforms, DNAnexus